Sarah Holland
Obstetrics & Gynecology · Little Rock, ARNPI 1306211966
Payments from drug & device makers
Across 151 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$453
- Astellas Pharma US Inc$421
- Sumitomo Pharma America, Inc.$278
- Pfizer$259
- Bayer$210
- AbbVie$161
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,040100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 23 | $453 |
| Astellas Pharma US Inc | 15 | $421 |
| Sumitomo Pharma America, Inc. | 12 | $278 |
| Pfizer | 18 | $259 |
| Bayer | 10 | $210 |
| AbbVie | 8 | $161 |
| Myovant Sciences Inc. | 12 | $154 |
| Amgen | 9 | $145 |
| Medline Industries LP | 1 | $132 |
| Organon | 6 | $126 |
| Exeltis, USA Inc. | 6 | $102 |
| Therapeuticsmd, Inc. | 4 | $82 |
| Merck | 4 | $74 |
| Evofem Biosciences, Inc. | 4 | $73 |
| Mylan Pharmaceuticals Inc. | 4 | $58 |
| Scynexis, Inc. | 3 | $55 |
| Aspira Women's Health Inc | 1 | $50 |
| Agile Therapeutics, Inc. | 3 | $49 |
| Roche Diagnostics Corporation | 1 | $28 |
| Mycovia Pharmaceuticals, Inc. | 1 | $22 |
| Millicent US Inc | 1 | $22 |
| Biogen | 1 | $20 |
| Coopersurgical, Inc. | 1 | $18 |
| Minerva Surgical, Inc | 1 | $18 |
| Vertex | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,040 in reported general payments places this provider in the 65th percentile of 272 obstetrics & gynecology providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 16 | $6,952 |
| Estradiol | 96 | $5,389 |
| Alendronate Sodium | 34 | $273 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 18 | $198 |
| Fluconazole | 23 | $99 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $259 | $6,95216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 272 obstetrics & gynecology providers in Arkansas.
Other obstetrics & gynecology in Little Rock
- Nathan LiversLittle Rock$1.5M
- Michael CopeLittle Rock$147K
- Nirvana ManningLittle Rock$47K
- David ShenkerLittle Rock$28K
- Fred NewtonLittle Rock$27K
- Julia GoodwinLittle Rock$16K
- Richard WyattLittle Rock$14K
- Ananth RanganathanLittle Rock$11K
- Mary RacherLittle Rock$11K
- Sharai AmayaLittle Rock$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.